Profitability is one of the main factors one must look at when analyzing a company. It is not only the reason behind a company�� existence, but also a key element when determining whether to invest in a company or not. Thus, in this article I will look into Symantec Corp (SYMC)麓s earnings and earnings growth (which came in better than expected on the last reported quarter), profit margins and other profitability ratios.
Additionally, I will evaluate which institutional investors bought the stock in the recent quarters (institutional backup can tell a lot about a stock), and the initiatives that the company is putting in motion in order to ameliorate its sales and margins.
Earnings
The first step is analyzing Symantec Corp�� earnings growth. I am looking for companies that are able to expand both their quarterly and annual earnings by more than 15% a year. Last quarter the company generated 13% quarterly EPS growth when compared to the same quarter last year. Thus, I am not encouraged by SYMC�� numbers. Past growth winners (Apple, Baidu, etc.) generated consistent quarterly EPS growth above 15% and I am certainly looking for that level before investing.
10 Best Energy Stocks To Own For 2015: AmREIT Inc (AMRE)
AmREIT, Inc. (AmREIT) is a full service, vertically integrated and self-administered real estate investment trust (REIT) that owns, operates, acquires and selectively develops and redevelops primarily neighborhood and community shopping centers located in high-traffic, densely populated, affluent areas with high barriers to entry. The Company seeks to own properties in cities in the United States that contain submarkets with characteristics comparable to its existing markets. The Company's shopping centers are anchored by national and local retailers, including supermarket chains, drug stores and other necessity-based retailers. The Company's tenant consists primarily of specialty retailers and local restaurants. The Company has acquired, owned and operated retail properties across 19 states. On December 12, 2012, the Company completed the acquisition of the Preston Royal Village Shopping Center, a retail shopping center, containing approximately 230,000 square feet of GLA. In June 2013, AmREIT Inc announced that it has completed the acquisition of Fountain Oaks Shopping Center, a 160,600 square foot Kroger-anchored shopping center in the north Buckhead submarket of Atlanta, Georgia. Effective September 24, 2013, AmREIT Inc, through its AmREIT Realty Investment Corp subsidiary, acquired Woodlake Square Shopping Center, an owner and operator of shopping centers.
The Company and its affiliates and predecessors acquired and developed mainly single-tenant retail properties across the United States, including in markets in California, Colorado, Georgia, Illinois, Kansas, Louisiana, Maryland, Minnesota, Missouri, New Mexico, New York, North Carolina, Oregon, Tennessee, Texas, Utah and Virginia. As of December 31, 2012, the Company's single tenant properties only comprised 9.6% of its total GLA and 8.1% of its annualized base rent. The Company's investment focus is predominantly concentrated in the affluent, high-growth submarkets of Houston, Dallas, San Antonio, Austin and Atlanta (collectively! , the Company's Core Markets), which represent five of the top population and job growth markets in the United States. The Company carefully review potential acquisitions that meet its investment criteria, performing rigorous and detailed analyses, including analyses of submarket demographics, location, tenants, retail sales, rental rates and projected returns.
The Company's redevelopment and expansion initiatives also may include expanding or reconfiguring existing retail space, developing pad sites or building other property types adjacent to the Company's existing shopping centers, thereby creating mixed-use properties that augment its retail operations and generate revenue enhancing opportunities for such properties. The Company sponsored and managed 20 advised funds targeting third-party equity capital, 13 of which have since been fully liquidated. With respect to the remaining seven Advised Funds, as of December 31, 2012, the Company managed three institutional joint ventures and four high net worth Advised Funds, which owned an aggregate of 2.2 million square feet of retail shopping center space. The Company's institutional partners in the joint ventures are J.P. Morgan Investment Management and AEW Capital.
As of December 31, 2012, the Company's portfolio consisted of 32 wholly-owned properties with approximately 1.5 million square feet of GLA, which were 96.7% leased and occupied with a weighted average remaining lease term of 5.2 years. The Company's neighborhood and community shopping centers accounted for 90.4% of the Company's GLA and 91.9% of its annualized base rent as of December 31, 2012. The Company's single-tenant retail properties comprised 9.6% of the Company's GLA and 8.1% of its annualized base rent.
As of December 31, 2012, the Company's Advised Funds included four high net worth investment funds, one institutional joint venture with J.P. Morgan Investment Management, one institutional joint venture with AEW Capital and one joint venture wi! th two of! its high net worth investment funds, MIG III and MIG IV. As of December 31, 2012, the Company's Advised Funds held all or a portion of the ownership interests in 17 properties with approximately 2.2 million square feet of GLA.
The Company's real estate operating and development business focuses on acquiring, managing, leasing and providing development and redevelopment services for its wholly-owned properties as well as the properties held by its Advised Funds. By employing the Company's own real estate team, the Company is able to provide all services to its properties in-house and maintain secure relationships with its tenants. The Company's real estate operating and development business is held under the Company's taxable REIT subsidiary, ARIC. ARIC generates brokerage, leasing, construction management, development and property management fee income.
Advisors' Opinion:- [By Anna Prior]
Shopping-center owner AmREIT Inc.(AMRE) said it is evaluating a $433 million unsolicited takeover bid from Regency Centers Corp.(REG) AmREIT’s Class B shares slipped 8.7% to $20.50 premarket after jumping some 17% in Thursday trading.
Hot Dow Dividend Companies To Buy For 2014: Fresnillo PLC (FRES)
Fresnillo plc is a silver and gold mining company. The Company, along with its subsidiaries, is engaged in the mining and beneficiation of non-ferrous minerals, and the sale of related production. The primary contents of this production include silver, gold, lead and zinc. The Company has six operating mines: the Fresnillo mine, located in the State of Zacatecas, which is primary silver mine; the Saucito mine, located in the State of Zacatecas, an underground silver mine; the Cienega mine, located in the State of Durango, an underground gold mine, including the San Ramon satellite mine; the Herradura mine, located in the State of Sonora, an open pit gold mine; the Soledad-Dipolos mine, located in the State of Sonora, an open pit gold mine, and the Noche Buena mine, located in State of Sonora, an open pit gold mine. Advisors' Opinion:- [By Alexis Xydias]
The FTSE All-Share Mining Index rose 3 percent. Randgold, a producer of the metal in Africa, advanced 6.8 percent to 4,722 pence. Fresnillo Plc (FRES), which operates silver and gold mines in Mexico, rallied 8.2 percent to 1,035 pence.
Hot Dow Dividend Companies To Buy For 2014: Centrais Eletricas Brasileiras SA (ELET6)
Centrais Eletricas Brasileiras SA (Eletrobras) is a Brazil-based holding company engaged in the electric power generation, transmission and distribution. The Company operates and maintains hydroelectric power plants, thermal power plants, nuclear power plants and wind/solar power plants. The Company acts as an agent for managing and investing government funds related to the energy sector, such as the Global Reversion Reserve (RGR), Fuel Consumption Account (CCC) and Energy Development Account (CDE). The Company also manages government programs, such as the National Electric Energy Conservation Program (Procel), the National Program for the Universalization of Access and Use of Electricity (Luz Para Todos) and the Alternative Energy Sources Incentive Program (Proninfa). In October, 2013, the Company acquired a 50% stake in the share capital of Rouar SA, held by Administracion Nacional de Usinas y Transmisiones Electricas UTE. Advisors' Opinion:- [By Patricia Lara]
Tractebel leapfrogged Cia. Energetica de Minas Gerais, CPFL Energia SA (CPFE3) and Centrais Eletricas Brasileiras SA (ELET6) in the fourth quarter to become the biggest utility after sidestepping pressure to cut rates because its contracts don�� expire for at least 14 years. Florianopolis, Brazil-based Tractebel has gained 11 percent in the past year, less than Sabesp�� 36 percent rally, which is the most of any utility on the Bovespa index.
Hot Dow Dividend Companies To Buy For 2014: Hancock Holding Company(HBHC)
Hancock Holding Company, a financial holding company, provides various banking and financial services in south Mississippi, Louisiana, South Alabama, and Florida. The company accepts various deposit products that include non-interest bearing demand deposits, NOW account deposits, money market deposits, savings deposits, and time deposits. Its loan portfolio comprises provision of commercial, consumer, commercial leasing, and real estate loans to consumers and small and middle market businesses. Hancock also offers various trust services that include operating as an executor, administrator, or guardian in administering estates; provision of investment custodial services for individuals, businesses, and charitable and religious organizations, as well as investment management services on an agency basis; and trustee services for pension plans, profit sharing plans, corporate and municipal bond issues, living trusts, life insurance trusts, and various other types of trusts cre ated for individuals, businesses, and charitable and religious organizations. In addition, it provides consumer financing services; owns, manages, and maintains real property; offers general insurance agency services; holds investment securities; markets credit life insurance; and engages in discount investment brokerage services, as well as owns approximately 3,700 acres of timber land in Hancock County, Mississippi. The company operates 182 banking and financial services offices and 161 automated teller machines. Hancock Holding Company was founded in 1899 and is headquartered in Gulfport, Mississippi.
Advisors' Opinion:- [By Eric Volkman]
Hancock Holding (NASDAQ: HBHC ) is resolutely sticking to its longtime dividend policy. Matching the same common stock payout it's distributed since September 2006, the financial services concern has declared a distribution of $0.24 per share. This is to be paid on September 16 to shareholders of record as of September 5.
- [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:
1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number
CTBI is trading at a premium to all four valuations above. The stock is trading at a 53.5% premium to its calculated fair value of $29.43. CTBI did not earn any Stars in this section.
Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:
1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%
CTBI earned one Star in this section for 1.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The company has paid a cash dividend to shareholders every year since 1988 and has increased its dividend payments for 33 consecutive years.
Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:
1. NPV MMA Diff.
2. Years to > MMA
The negative NPV MMA Diff. means that on a NPV basis the dividend earnings from an investment in CTBI would be less than a similar amount invested in MMA earning a 20-year average rate of 3.41%. If CTBI grows its dividend at 1.5% per year, it will never equal a MMA yielding an estimated 20-year average rate of 3.41%.
Memberships and Peers: CTBI is, a member of the Broad Dividend Achieve
Hot Dow Dividend Companies To Buy For 2014: Biodel Inc (BIOD)
Biodel Inc. (Biodel), incorporated on December 3, 2003, is a development-stage speciality biopharmaceutical company focused on the development and commercialization of treatments for diabetes. The Company develops its product candidates by applying its formulation technologies to existing drugs. Its advanced program involves developing formulations of injectable recombinant human insulin (RHI). In addition to its ultra-rapid-acting insulin formulations, the Company has developed prototype formulations of a liquid glucagon, a basal insulin and a glucose responsive insulin, in each case for use by patients with diabetes. RHI-based formulation known as Linjeta was the subject of a New Drug Application (NDA).
The Company has two pivotal Phase III clinical trials with its preferred commercial formulation of Linjeta prior to re-submitting the NDA. In August 2011, it completed patient visits and analyzed top-line data from the first Phase 1 clinical trial of two RHI-based formulations. The trial was a single-center, randomized, double-blind, three-period crossover trial in 18 subjects with Type 1 diabetes. The purpose of the trial was to evaluate the pharmacokinetic and pharmacodynamic characteristics and injection site toleration of BIOD-105 and BIOD-107, as compared to the insulin analog marketed as Humalog. The Company conducted Phase I, Phase II and Phase III clinical trials comparing the performance of its Linjeta formulation of RHI to either Humulin, which is a branded formulation of RHI or Humalog. Its pivotal Phase III clinical trials were open-label, parallel group, randomized trials conducted at centers in the United States, Germany and India.
The Company competes with Eli Lilly, Novo Nordisk, Sanofi-Aventis, Halozyme Therapeutics, Inc. and MannKind Corporation.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 specialty biopharmaceutical player that's starting to trend within range of triggering a big breakout trade is Biodel (BIOD), which is focused on the development and commercialization of innovative treatments for diabetes. This stock has been hit hard by the bears over the last three months, with shares down by 24%.
If you take a look at the chart for Biodel, you'll notice that this stock is ripping higher here right off its 50-day moving average of $2.32 a share with strong upside volume. Volume on Thursday has so far registered over 750,000 shares, which is well above its three-month average action of 445,084 shares. This move is quickly pushing shares of BIOD within range of triggering a big breakout trade.
Traders should now look for long-biased trades in BIOD if it manages to break out above some near-term overhead resistance levels at $2.52 to $2.60 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 445,084 shares. If that breakout triggers soon, then BIOD will set up to re-test or possibly take out its next major overhead resistance levels $3 to its 200-day moving average of $3.39 a share. Any high-volume move above $3.39 will then give BIOD a chance to tag $4 a share.
Traders can look to buy BIOD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support at $2.10 a share. One can also buy BIOD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Monica Gerson]
Biodel (NASDAQ: BIOD) is expected to post a Q1 loss at $0.24 per share.
First Majestic Silver (NYSE: AG) is estimated to post its Q1 earnings at $0.10 per share on revenue of $63.35 million.
Hot Dow Dividend Companies To Buy For 2014: HMS Holdings Corp (HMSY)
HMS Holdings Corp. provides cost containment, coordination of benefits, and program integrity services. The company?s services enable clients to recover amounts due from liable third parties, reduce fraud, and ensure regulatory compliance. Its coordination of benefits services route claims paid by a government program to the liable third party, which reimburses the government payor; cost avoidance services provide validated insurance coverage information that is used by government payors to reject claims that are the responsibility of a third party; and program integrity services are designed to identify payment errors and recover the erroneous payments. The company also offers audit programs, program design, benefit management, and general and pharmacy systems consulting services. It serves state Medicaid agencies, Medicaid and Medicare managed care plans, government and private self-funded employers, pharmacy benefit managers, child support agencies, the Veterans Health Administration, the Centers for Medicare and Medicaid Services, commercial plans, healthcare payors and sponsors, business outsourcing and technology firms, and government. The company was founded in 1974 and is headquartered in New York, New York.
Advisors' Opinion:- [By Seth Jayson]
HMS Holdings (Nasdaq: HMSY ) is expected to report Q2 earnings on July 26. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict HMS Holdings's revenues will increase 3.0% and EPS will shrink -8.7%.
Hot Dow Dividend Companies To Buy For 2014: Delcath Systems Inc.(DCTH)
Delcath Systems, Inc., a development stage company, operates as a specialty pharmaceutical and medical device company. It focuses on cancers in the liver. The company involves in the development and clinical study of the Delcath chemosaturation system. Its clinical trial include a Phase III multi-center study for patients with unresectable metastatic ocular or cutaneous melanoma exclusively or predominantly in the liver; and a multi-arm Phase II clinical trial of the Delcath chemosaturation system with melphalan in patients with primary and metastatic liver cancer, which comprise neuroendocrine tumors, hepatocellular carcinoma, ocular or cutaneous melanoma, and metastatic adenocarcinoma. Delcath Systems, Inc. was founded in 1988 and is based in New York, New York.
Advisors' Opinion:- [By John Udovich]
Biotech in general has been one of the market�� hottest sectors this year thanks to plenty of mostly good news�along with�new IPOs while small cap biotech stocks Delcath Systems (NASDAQ: DCTH), ZIOPHARM Oncology Inc (NASDAQ: ZIOP), Recro Pharma (NASDAQ: REPH), TetraLogic Pharmaceuticals (NASDAQ: TLOG)�and TNI BioTech (OTCMKTS: TNIB) have also produced their share of news�this week or in recent weeks. Just consider the following:
- [By Monica Gerson]
Delcath Systems (NASDAQ: DCTH) is expected to post a Q4 loss at $0.05 per share on revenue of $100.00 thousand.
Emerald Oil (NYSE: EOX) is projected to post a Q4 loss at $0.02 per share on revenue of $18.04 million.
No comments:
Post a Comment